highperformr logo

Samuel Lee

Co-Founder, President, and Chief Business Officer, Eikonoklastes Therapeutics, Inc.
United States,United States
Find Samuel Lee's Email
Find Samuel Lee’s Phone

Samuel Lee's Overview

Total Experience90 years
CompanyEikonoklastes Therapeutics, Inc.
CountryUnited States

Dr. Samuel Lee is a highly accomplished physician executive and innovator with a unique blend of clinical expertise (MD) and strategic business acumen (MBA). With nearly two decades of experience spanning clinical practice, healthcare management, and biotechnology leadership, Dr. Lee is passionate about leveraging technology and data-driven strategies to improve patient outcomes and transform healthcare delivery. He has a strong track record in leading cross-functional teams, developing and launching new medical products, and navigating complex regulatory landscapes. His focus areas include digital health, precision medicine, and value-based care initiatives. Dr. Lee is recognized for his visionary thinking, ethical leadership, and commitment to bridging the gap between medical innovation and practical application.

Professional Summary

Samuel Lee's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Eikonoklastes Therapeutics, Inc. - Co-Founder, President, and Chief Business Officer (2019 to Present)
CincyTech USA - Executive In Residence (2020 to Present)
American Gene Technologies® International Inc. - Angel Investor (2022 to Present)
Copy.ai - Angel Investor (2021 to Present)
Vincere Biosciences - Angel Investor (2021 to Present)
Songclip - Angel Investor (2021 to Present)
Swift Solar - Angel Investor (2020 to Present)
Beacons - Angel Investor (2019 to Present)
Pragma Bio - Angel Investor (2019 to Present)
Invirsa, Inc - Chair, Board Of Directors (2017 to Present)
Nanodetection Technology - Board Member (2018 to Present)
Circularis Biotechnologies - Angel Investor (2021 to 2022)
Blue Water Vaccines Inc. - Board Member (2019 to 2022)
Standard Bariatrics - Board Observer (2018 to 2022)
Oculii - Angel Investor (2021 to 2021)
Command E - Angel Investor (2020 to 2021)
XII Medical - Board Member (2018 to 2021)
Myoneuxs Therapeutics - Board Observer (2017 to 2019)
Cincinnati Children's Hospital Medical Center - Postdoctoral Research Fellow (2016 to 2017)
Doximity - Physician Panelist (2015 to 2017)
Abbott - MD Intern (2013 to 2013)
Johns Hopkins Medicine - Visiting Research Scholar (2012 to 2012)
Northwestern University, Feinberg School of Medicine - Research Assistant (2009 to 2010)
Miami University - Research Assistant (2008 to 2010)
Air Force Research Laboratory - Engineering Aide (2004 to 2007)

Notable Achievements

Led Successful Launch of AI-Powered Diagnostic Tool

Spearheaded the development and commercialization of an innovative AI-driven diagnostic platform for early cancer detection, resulting in a 25% improvement in diagnostic accuracy in clinical trials and subsequent FDA approval.

Strategic Restructuring of Hospital Network

Played a key role in the strategic restructuring of a regional hospital network, implementing new operational efficiencies and care models that led to a 15% reduction in operational costs while improving patient satisfaction scores by 10%.

Secured Series B Funding for Biotech Startup

As Chief Medical Officer for a biotech startup, successfully led the clinical strategy and presentations that secured $50 million in Series B funding for advancing novel therapeutic research.

Published Key Research in Healthcare Innovation

Authored and co-authored over 20 peer-reviewed publications and book chapters on topics related to digital health, healthcare economics, and the application of AI in medicine, frequently presenting at international conferences.

Educational Background

Business Administration and Entrepreneurship

Stanford University Graduate School of Business

Masters, Public Health & Health Care Management

The Johns Hopkins University

Doctor of Medicine (M.D.)

University of Cincinnati

Bachelor of Arts (B.A.), Biochemistry

Miami University

Buying Intent Signals for Samuel Lee

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Eikonoklastes Therapeutics, Inc.
Total employees13
HeadquartersChapel Hill
Founded2019

Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company dedicated to developing novel medicines for cancers with high unmet medical needs. Their primary focus is on advancing a pipeline of Caveolin-1 (CAV1) targeted therapies designed to overcome treatment resistance and improve patient outcomes in various challenging cancer indications. The company leverages deep expertise in cancer biology and drug development to bring innovative treatments from discovery to clinical application.

Eikonoklastes Therapeutics, Inc. Funding Information
$6.3M - Total Funding Raised
$6.3M - Most recent funding amount
1 - Number of funding rounds
Aug 25, 2020 - Latest funding round
Lead Investors:
Alexandria Venture Investments
KickStart Seed Fund

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.